Analyzing the Rise and Fall of Pfizer Stock and Investment Potential

Exploring the fluctuations in Pfizer's stock value due to declining COVID-related sales and upcoming patent expirations, alongside the company's acquisition strategy and challenges in drug development. Despite setbacks, the chapter recommends Pfizer as a promising investment opportunity based on recent financial performance and business stability.